Lv21
110 积分 2023-09-09 加入
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)
4小时前
待确认
A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
4小时前
已完结
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis
2个月前
已关闭
The skin in primary immunodeficiency disorders
3个月前
已关闭
Skin disorders are prominent features in primary immunodeficiency diseases: A systematic overview of current data
3个月前
已完结
Domiciliary Fractional Exhaled Nitric Oxide and Spirometry in Monitoring Asthma Control and Exacerbations
5个月前
已完结
Long‐term predictors of loss of asthma control in school‐aged well‐controlled children with mild to moderate asthma: A 5‐year follow‐up
5个月前
已完结
Proceedings from the inaugural Artificial Intelligence in Primary Immune Deficiencies (AIPID) conference
6个月前
已完结
Electronic health record signatures identify undiagnosed patients with common variable immunodeficiency disease
6个月前
已完结
Eye Involvement in Hyperimmunoglobulinemia E (Job's) Syndrome
6个月前
已完结
皖公网安备34019202002308
